Seamless phase II-III adaptive trial design elements for progressive MS: Neurofilament light chain (phase II/interim endpoint), phase III endpoints and patient populations

Authors
Category Systematic review
JournalMultiple Sclerosis Journal
Year 2019
This article has no abstract
Epistemonikos ID: a7873e2558b378b97a106ed73bae01254b1dfd53
First added on: Feb 11, 2025